STOCK TITAN

PINEAPPLE EXPRES CANNABIS (PNXP) Financials

PNXP OTC
Trailing 12 months to October 31, 2025
Revenue $0 YoY not available
Net Income -$653K YoY not available
EPS (Diluted) Not reported for the trailing 12 months
Operating Cash Flow $905K YoY not available
Market Cap $96K as of Oct 29, 2026
Price / Sales n/m revenue is not positive, trailing 12 months to October 31, 2025
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to October 31, 2025
Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings Latest period Q3 FY2026, ended Oct 31, 2025 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q3 FY2026, filed Dec 19, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PNXP SEC filings page.

PINEAPPLE EXPRES CANNABIS (PNXP) reported $0 in revenue over the twelve months to Oct 31, 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.

Rhea AI PNXP FY2025

The reported business shrank sharply, while persistent overhead, negative equity, and financing needs outweighed its small revenue base.

Operating margin moved from 64.5% in FY2021 to -303.0% in FY2023, showing that the smaller operation could not absorb its operating structure. SG&A was still $22K in FY2023, so the margin collapse reflects cost burden against reduced activity rather than merely weaker gross economics.

Revenue fell from $30K in FY2021 to $5K in FY2023, leaving much less activity to support the business. By FY2023, liabilities of $547K stood against only $2K of assets, indicating an extremely liability-funded balance sheet.

Operating cash flow was -$17K in FY2023 while financing cash flow was $11K, meaning financing inflows offset only part of the operating cash requirement. The current ratio fell from 0.1x in FY2022 to 0.0x in FY2023, consistent with minimal current assets relative to current obligations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

PINEAPPLE EXPRES CANNABIS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Earnings Quality No Cash Backing
N/A

PINEAPPLE EXPRES CANNABIS reported a net loss of $31K while operations used $45K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0
YoY-100.0%
QoQn/m

PINEAPPLE EXPRES CANNABIS generated $0 in revenue in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
$20K
YoYn/m
QoQ+22.8%

PINEAPPLE EXPRES CANNABIS reported $20K in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 22.8%.

EBITDA

Not reported for Q3 2026.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$0
YoY-100.0%
QoQn/m

PINEAPPLE EXPRES CANNABIS held $0 in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
43M
QoQ+13.4%

PINEAPPLE EXPRES CANNABIS had 43M shares outstanding in Q3 2026. Against the prior quarter it is up 13.4%.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

None of these metrics is reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

PNXP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PNXP quarterly income statement
MetricQ3'2610-QQ2'26FilingQ1'26FilingQ4'25FilingQ3'2510-QQ2'25FilingQ1'25FilingQ4'24Filing
Revenue$0-100.0%$0-100.0%$0-100.0%$0$4K$10K$2KN/A
Gross ProfitN/AN/AN/AN/A$4K$10K$2KN/A
SG&A Expenses$0-100.0%$1K-80.5%$544-90.3%$2K$6K+163.8%$6K-71.0%$6K-81.2%N/A
Operating Income$111Kn/m-$246K-5839.1%-$185Kn/m-$16K-$1Kn/m$4Kn/m-$4Kn/mN/A
EBITDAN/AN/AN/AN/A-$1Kn/m$4Kn/m-$4Kn/mN/A
Interest Expense$99Kn/m$101Kn/m$128Kn/mN/A$0$0$0N/A
Income Tax$0n/m$0n/m$0n/m$0$0$0$0N/A
Net Income$20Kn/m$17K+288.1%-$659Kn/m-$31K-$1Kn/m$4K-99.3%-$4K-102.0%N/A
EPS (Basic)-$0.01$0.00-$0.03n/m$0.00n/m$0.00n/m$0.00-100.0%$0.00n/m-$0.01
EPS (Diluted)N/AN/AN/AN/A$0.00n/m$0.00-100.0%$0.00n/m-$0.03
Diluted Shares (Avg)N/AN/AN/AN/A20M-2.5%20M-2.5%20M-2.3%N/A

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses.

PNXP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PNXP quarterly balance sheet
MetricQ3'2610-QQ2'26FilingQ1'26FilingQ4'25FilingQ3'2510-QQ2'25FilingQ1'25FilingQ4'24Filing
Total Assets$190K-93.7%$190K-93.7%$190K-96.2%$0-100.0%$3.0M+180.4%$3.0M+222.1%$5.0M+1442.2%$2K-18.7%
Current Assets$0-100.0%$0-100.0%$0-100.0%$0-100.0%$15K$10K$2K$30n/m
Cash & Equivalents$0-100.0%$0n/m$0n/m$0-100.0%$1K$0$0$30n/m
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0$0$0$0n/m
Accounts ReceivableN/AN/AN/AN/A$14K$10K$2KN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0$0$0$0n/m
Total Liabilities$8.3M+179.2%$8.4M+180.6%$8.4M+68.7%$2K-88.3%$3.0M+18970.8%$3.0M+18928.3%$5.0M+25828.3%$18K-96.7%
Current Liabilities$8.3M+179.2%$8.4M+180.6%$8.4M+72803.1%$2K-88.3%$3.0M+18970.8%$3.0M+18928.3%$12K-40.0%$18K-96.7%
Non-Current Liabilities$0n/m$0n/m$0-100.0%$0n/m$0n/m$0n/m$5.0Mn/m$0n/m
Total Equity-$8.2M-28709.9%-$8.2M-27588.6%-$8.2M-32338.6%-$2Kn/m$29K-97.3%$30K-96.8%$25K-91.7%-$16Kn/m
Retained Earnings-$1.3Mn/m-$1.3Mn/m-$1.3Mn/m-$674Kn/m-$924K-362.8%-$923K-538.4%-$927Kn/m-$642Kn/m

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

PNXP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PNXP quarterly cash flow statement
MetricQ3'2610-QQ2'26FilingQ1'26FilingQ4'25FilingQ3'2510-QQ2'25FilingQ1'25FilingQ4'24Filing
Operating Cash Flow$2Kn/m$0n/m$937Kn/m-$33K-$19n/m$0n/m-$12Kn/mN/A
Depreciation & AmortizationN/AN/AN/AN/A$1150.0%$1150.0%$1150.0%$115n/m
Investing Cash Flow$0n/m$0n/m-$190Kn/mN/A$0$0$0N/A
Financing Cash Flow-$2K-514.7%$0n/m-$747K-6475.9%$33K$430-78.5%$0-100.0%$12K+0.1%N/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

PNXP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PNXP quarterly financial ratios
MetricQ3'2610-QQ2'26FilingQ1'26FilingQ4'25FilingQ3'2510-QQ2'25FilingQ1'25FilingQ4'24Filing
Gross MarginN/AN/AN/AN/A100.0%100.0%100.0%N/A
Operating MarginN/AN/AN/AN/A-28.8%43.5%-184.1%N/A
Net MarginN/AN/AN/AN/A-28.8%43.5%-184.1%N/A
Return on EquityN/AN/AN/AN/A-4.4%-4.2pp14.4%-52.4pp-14.2%-73.0ppN/A
Return on Assets10.8%+10.8pp8.8%+8.6pp-347.0%-346.9ppN/A0.0%+0.2pp0.1%-65.5pp-0.1%-55.4ppN/A
Current Ratio0.000.0x0.000.0x0.00-0.2x0.000.0x0.010.000.170.000.0x
Liabilities-to-EquityN/AN/AN/AN/A104.85+104.8x100.23+100.2x195.55+195.5xN/A
Asset Turnover0.000.0x0.000.0x0.000.0xN/A0.000.000.00N/A

Not reported in any period shown, so not listed: Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$2K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PINEAPPLE EXPRES CANNABIS's annual revenue?

PINEAPPLE EXPRES CANNABIS (PNXP) reported $16K in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is PINEAPPLE EXPRES CANNABIS profitable?

No, PINEAPPLE EXPRES CANNABIS (PNXP) reported a net loss of $653K over the trailing 12 months to October 31, 2025. In fiscal year 2025 it reported a net loss of $31K.

What is PINEAPPLE EXPRES CANNABIS's operating cash flow?

PINEAPPLE EXPRES CANNABIS (PNXP) recorded an outflow of $45K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

PINEAPPLE EXPRES CANNABIS (PNXP) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.

PINEAPPLE EXPRES CANNABIS (PNXP) had 21M shares outstanding as of fiscal year 2025.

PINEAPPLE EXPRES CANNABIS (PNXP) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

PINEAPPLE EXPRES CANNABIS (PNXP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to October 31, 2025). The market capitalization is $96K as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

PINEAPPLE EXPRES CANNABIS (PNXP) has no price-to-sales ratio at the moment: revenue is not positive (trailing 12 months to October 31, 2025). The market capitalization is $96K as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, PINEAPPLE EXPRES CANNABIS (PNXP) held $0 in cash, cash equivalents and investments, and reported an operating cash outflow of $45K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

PINEAPPLE EXPRES CANNABIS (PNXP) has negative shareholder equity of -$2K as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

PINEAPPLE EXPRES CANNABIS (PNXP) reported a net loss of $31K while operations used $45K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top